Evidence map›Paper›PMID 20225037›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2010

Strategies to insulate lentiviral vector-expressed transgenes.

Ali Ramezani, Robert G Hawley

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Decoding RNA Metabolism by RNA-linked CRISPR Screening in Human Cells.bioRxiv : the preprint server for biology · 2024
    Article
  5. Advances in HIV Gene Therapy.International journal of molecular sciences · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Mammalian cell proliferation requires noncatalytic functions of O-GlcNAc transferase.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Ali RamezaniDepartment of Anatomy and Regenerative Biology, The George Washington University Medical Center, Washington, DC, USA.
Robert G Hawley
George Washington University · USWashington University Medical Center · US

Funding

Molecular Chimerism Therapy for Hemophilia AR01HL065519 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI HAWLEY, ROBERT G. · 2001 to 2009
$3.0M
Embryoid Body-derived Hematopoietic Stem Cell LinesR01HL066305 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI HAWLEY, ROBERT G. · 2001 to 2005
$1.7M
NHLBI NIH HHS R01 HL065519NHLBI NIH HHS R01 HL066305NHLBI NIH HHS R01HL65519NHLBI NIH HHS R01HL66305
6 · The paper itself

Abstract

Lentiviruses are capable of infecting many cells irrespective of their cycling status, stably inserting DNA copies of the viral RNA genomes into host chromosomes. This property has led to the development of lentiviral vectors for high-efficiency gene transfer to a wide variety of cell types, from slowly proliferating hematopoietic stem cells to terminally differentiated neurons. Regardless of their advantage over gammaretroviral vectors, which can only introduce transgenes into target cells that are actively dividing, lentiviral vectors are still susceptible to chromosomal position effects that result in transgene silencing or variegated expression. In this chapter, various genetic regulatory elements are described that can be incorporated within lentiviral vector backbones to minimize the influences of neighboring chromatin on single-copy transgene expression. The modifications include utilization of strong internal enhancer-promoter sequences, addition of scaffold/matrix attachment regions, and flanking the transcriptional unit with chromatin domain insulators. Protocols are provided to evaluate the performance as well as the relative biosafety of lentiviral vectors containing these elements.

Indexed as

Genetic VectorsTransgenesEnhancer Elements, GeneticGene SilencingHumansK562 CellsLentivirusPromoter Regions, Genetic

Identifiers

PMID20225037
PMCPMC3279150
OpenAlexW143454246

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.